Political uncertainty will proceed in 2020, however the rise of the electrical automotive and a change in sentiment in direction of healthcare shares may present reduction for buyers, in accordance with the supervisor of the Aviva Traders International Fairness Revenue fund.
Richard Saldanha stated the efficiency of auto and pharmaceutical firms over the longer-term will not be as impacted by politics as are different sectors, and so provide buyers a component of security in 2020.
He stated: “It’s set to be one other yr dominated by politics. The US election in November is prone to be the opposite main political occasion.
“Anticipate macroeconomic headlines to once more dominate over microeconomic ones for essentially the most half, though we nonetheless assume it pays for buyers to concentrate on the underlying fundamentals.
“Traders could look again on 2019 as a splendidly benign yr for world equities, with markets hitting new highs, regardless of fears of an financial slowdown and commerce tensions effervescent beneath the floor.”
He stated one potential space of worth for buyers was know-how firms that equipped automotive producers.
Mr Saldanha stated: “The auto sector was definitely beneath strain and stays a tricky space for buyers to navigate, notably given the required shifts of present inside combustion engine fleets to hybrid and electrical autos, with probably heavy fines for these whose fleets don’t adjust to harder emissions requirements.
“Maybe unsurprisingly, confronted with the burden of declining gross sales and better analysis and growth prices because of these technological adjustments, auto firms are taking a look at methods to consolidate, both by means of platform tie-ups or outright mergers.
“We predict this pattern is about to proceed, however buyers ought to have a look at all elements of the electrical automobile worth chain, from battery producers by means of to the tech firms which provide the semiconductors which can be going to be more and more utilized in these subsequent era autos.”
He added that buyers have been nervous in regards to the affect of the US presidential election on healthcare firms, as they feared sure election outcomes may result in decrease income for pharmaceutical firms.
Mr Saldanha stated: “Healthcare shares endured a tricky 2019, with elevated focus round drug pricing and political headlines across the ‘Medicare for all’ coverage advocated by Democrat candidates Elizabeth Warren and Bernie Sanders inflicting many buyers to stay on the sidelines.
“Whereas we don’t anticipate these headlines to abate within the build-up to the US elections, there may very well be a possibility for long-term buyers who’re prepared to abdomen a few of this political danger within the short-term.
“Medical insurance firms – who’re more and more centered on utilizing information to drive higher affected person outcomes – are one instance, as are pharma firms which have revolutionary pipelines in remedy areas with unmet wants which ought to keep away from among the pricing pressures many generic drug firms are dealing with.”
The Aviva Traders International Fairness Revenue fund has returned 12.1 per cent over the previous yr, simply shy of its sector, the IA International Fairness Revenue, which returned 12.7 per cent.